As set out in the written ministerial statement of 17 July 2006, Official Report, column 5WS, 28 out of 34 cancer networks reported that they were HER-2 testing all women diagnosed with early stage breast cancer. The remaining six reported that they would be testing all these women by the end of October 2006. These networks have since reported that they are now HER-2 testing all women with early breast cancer.